Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Lilly, Gilead, Amgen Started at Outperform by Bernstein
Novartis to Appeal Latest Setback to Stopping Entresto Generics
Larimar Therapeutics' New Drug Could Transform Treatment For Rare Neurological Disease, Analyst Sees Over 200% Upside For Stock
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
ViiV Reports Positive Real-world Data for HIV Prevention Drug
Donald Trump Extends Betting Odds Lead To 58:42—Here's How Kamala Harris Plans To Reverse The Trend
Deep Sea OP : The chart shows U shaped pattern. The stock is on the up trend.